2014
DOI: 10.1016/j.jinorgbio.2014.04.002
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, characterization, crystal structures and biological activity of set of Cu(II) benzothiazole complexes: Artificial nucleases with cytotoxic activities

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
10
0

Year Published

2015
2015
2018
2018

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 31 publications
(12 citation statements)
references
References 62 publications
1
10
0
Order By: Relevance
“…The apparent binding affinity of the all metal complexes was found to be in the range 2.93 x 10 −5 – 3.89 x 10 −5 M −1 . These results and the significant reduction in emission intensity expose that the examined compounds are stacking with base pairs of the DNA indicating the intercalation mode of binding . Thus, the results are in agreement with the electronic absorption spectra.…”
Section: Resultssupporting
confidence: 84%
“…The apparent binding affinity of the all metal complexes was found to be in the range 2.93 x 10 −5 – 3.89 x 10 −5 M −1 . These results and the significant reduction in emission intensity expose that the examined compounds are stacking with base pairs of the DNA indicating the intercalation mode of binding . Thus, the results are in agreement with the electronic absorption spectra.…”
Section: Resultssupporting
confidence: 84%
“…In these copper(II) complexes, chemical and biological activities are greatly affected by a ligand. A change of the substituent properties and binding site of the ligand can cause certain differences in the spatial configuration and electron cloud density distribution of the complexes, resulting in differences in DNA binding properties or bioactivities . Very recently, Kumar and co‐workers have observed that copper(II) complexes exhibit effective anticancer and antimicrobial activity via strongly binding and cleaving DNA, and the activity of the complexes varied with the ligand .…”
Section: Introductionmentioning
confidence: 99%
“…These compounds have been the subject of many mechanistic studies with the generally accepted mechanism being the binding of the platinum to guanine of DNA in the cell and thus causing cell death by apoptosis [5][6][7][8][9][10]. Recently, new platinum compounds and compounds with metal centers other than platinum have been investigated as a result of cisplatin's severe side-effects and problems with drug resistance [11][12][13][14][15][16][17]. DNA may or may not be the primary target of these other metal centers as proteins or other bimolecular interactions may be more important [18][19][20][21][22][23][24][25].…”
Section: Introductionmentioning
confidence: 99%
“…Ruthenium has been one metal that has been targeted as a replacement for platinumbased drugs due to its generally reduced host toxicity and interesting redox properties [1][2][3][4]26,27]. Both ruthenium(III) and organometallic ruthenium(II) species [5][6][7][8][9][10][28][29][30][31][32][33][34][35] have been studied and two ruthenium(III) complexes, NAMI-A and KP1019, [11][12][13][14][15][16][17]27,36] have completed phase I clinical trials. [18][19][20][21][22][23][24][25][37][38][39][40][41][42] In recent years, bioorganometallic compounds (defined as biologically active organometallic species)…”
Section: Introductionmentioning
confidence: 99%